# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-26-080930
Filing Date
2026-07-07
Accepted
2026-07-07 07:02:35
Documents
70
Period of Report
2026-07-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2619879d1_8k.htm iXBRL | 8-K | 26507
2 | EXHIBIT 99.1 | tm2619879d1_ex99-1.htm | EX-99.1 | 20939
3 | EXHIBIT 99.2 | tm2619879d1_ex99-2.htm | EX-99.2 | 83770
4 | GRAPHIC | tm2619879d1_ex99-1img001.jpg | GRAPHIC | 5294
5 | GRAPHIC | tm2619879d1_ex99-2img001.jpg | GRAPHIC | 42418
6 | GRAPHIC | tm2619879d1_ex99-2img002.jpg | GRAPHIC | 339311
7 | GRAPHIC | tm2619879d1_ex99-2img003.jpg | GRAPHIC | 189927
8 | GRAPHIC | tm2619879d1_ex99-2img004.jpg | GRAPHIC | 122174
9 | GRAPHIC | tm2619879d1_ex99-2img005.jpg | GRAPHIC | 159494
10 | GRAPHIC | tm2619879d1_ex99-2img006.jpg | GRAPHIC | 144579
11 | GRAPHIC | tm2619879d1_ex99-2img007.jpg | GRAPHIC | 118603
12 | GRAPHIC | tm2619879d1_ex99-2img008.jpg | GRAPHIC | 37659
13 | GRAPHIC | tm2619879d1_ex99-2img009.jpg | GRAPHIC | 202297
14 | GRAPHIC | tm2619879d1_ex99-2img010.jpg | GRAPHIC | 163755
15 | GRAPHIC | tm2619879d1_ex99-2img011.jpg | GRAPHIC | 172510
16 | GRAPHIC | tm2619879d1_ex99-2img012.jpg | GRAPHIC | 152224
17 | GRAPHIC | tm2619879d1_ex99-2img013.jpg | GRAPHIC | 126770
18 | GRAPHIC | tm2619879d1_ex99-2img014.jpg | GRAPHIC | 173417
19 | GRAPHIC | tm2619879d1_ex99-2img015.jpg | GRAPHIC | 148762
20 | GRAPHIC | tm2619879d1_ex99-2img016.jpg | GRAPHIC | 144128
21 | GRAPHIC | tm2619879d1_ex99-2img017.jpg | GRAPHIC | 182261
22 | GRAPHIC | tm2619879d1_ex99-2img018.jpg | GRAPHIC | 171879
23 | GRAPHIC | tm2619879d1_ex99-2img019.jpg | GRAPHIC | 151036
24 | GRAPHIC | tm2619879d1_ex99-2img020.jpg | GRAPHIC | 138585
25 | GRAPHIC | tm2619879d1_ex99-2img021.jpg | GRAPHIC | 165886
26 | GRAPHIC | tm2619879d1_ex99-2img022.jpg | GRAPHIC | 176655
27 | GRAPHIC | tm2619879d1_ex99-2img023.jpg | GRAPHIC | 154096
28 | GRAPHIC | tm2619879d1_ex99-2img024.jpg | GRAPHIC | 164407
29 | GRAPHIC | tm2619879d1_ex99-2img025.jpg | GRAPHIC | 189973
30 | GRAPHIC | tm2619879d1_ex99-2img026.jpg | GRAPHIC | 39984
31 | GRAPHIC | tm2619879d1_ex99-2img027.jpg | GRAPHIC | 139132
32 | GRAPHIC | tm2619879d1_ex99-2img028.jpg | GRAPHIC | 93146
33 | GRAPHIC | tm2619879d1_ex99-2img029.jpg | GRAPHIC | 199267
34 | GRAPHIC | tm2619879d1_ex99-2img030.jpg | GRAPHIC | 195143
35 | GRAPHIC | tm2619879d1_ex99-2img031.jpg | GRAPHIC | 167230
36 | GRAPHIC | tm2619879d1_ex99-2img032.jpg | GRAPHIC | 150351
37 | GRAPHIC | tm2619879d1_ex99-2img033.jpg | GRAPHIC | 156489
38 | GRAPHIC | tm2619879d1_ex99-2img034.jpg | GRAPHIC | 189922
39 | GRAPHIC | tm2619879d1_ex99-2img035.jpg | GRAPHIC | 126336
40 | GRAPHIC | tm2619879d1_ex99-2img036.jpg | GRAPHIC | 100893
41 | GRAPHIC | tm2619879d1_ex99-2img037.jpg | GRAPHIC | 97837
42 | GRAPHIC | tm2619879d1_ex99-2img038.jpg | GRAPHIC | 47920
43 | GRAPHIC | tm2619879d1_ex99-2img039.jpg | GRAPHIC | 187557
44 | GRAPHIC | tm2619879d1_ex99-2img040.jpg | GRAPHIC | 169174
45 | GRAPHIC | tm2619879d1_ex99-2img041.jpg | GRAPHIC | 143595
46 | GRAPHIC | tm2619879d1_ex99-2img042.jpg | GRAPHIC | 116471
47 | GRAPHIC | tm2619879d1_ex99-2img043.jpg | GRAPHIC | 120211
48 | GRAPHIC | tm2619879d1_ex99-2img044.jpg | GRAPHIC | 107430
49 | GRAPHIC | tm2619879d1_ex99-2img045.jpg | GRAPHIC | 44353
50 | GRAPHIC | tm2619879d1_ex99-2img046.jpg | GRAPHIC | 184302
51 | GRAPHIC | tm2619879d1_ex99-2img047.jpg | GRAPHIC | 136842
52 | GRAPHIC | tm2619879d1_ex99-2img048.jpg | GRAPHIC | 134732
53 | GRAPHIC | tm2619879d1_ex99-2img049.jpg | GRAPHIC | 144413
54 | GRAPHIC | tm2619879d1_ex99-2img050.jpg | GRAPHIC | 145229
55 | GRAPHIC | tm2619879d1_ex99-2img051.jpg | GRAPHIC | 169849
56 | GRAPHIC | tm2619879d1_ex99-2img052.jpg | GRAPHIC | 166212
57 | GRAPHIC | tm2619879d1_ex99-2img053.jpg | GRAPHIC | 126494
58 | GRAPHIC | tm2619879d1_ex99-2img054.jpg | GRAPHIC | 107315
59 | GRAPHIC | tm2619879d1_ex99-2img055.jpg | GRAPHIC | 117575
60 | GRAPHIC | tm2619879d1_ex99-2img056.jpg | GRAPHIC | 202675
| Complete submission text file | 0001104659-26-080930.txt |  | 11578150

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
61 | XBRL TAXONOMY EXTENSION SCHEMA | tvrd-20260707.xsd | EX-101.SCH | 3044
62 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | tvrd-20260707_lab.xml | EX-101.LAB | 34239
63 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | tvrd-20260707_pre.xml | EX-101.PRE | 22378
73 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2619879d1_8k_htm.xml | XML | 3221

Mailing Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478
Business Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478 (713) 489-8654
Tvardi Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 261157804
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)